Funder
Novartis Pharmaceuticals Corporation
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference29 articles.
1. Metcalf D (2012) A promising new treatment for refractory aplastic anemia. N Engl J Med 367(1):74–75. https://doi.org/10.1056/NEJMe1204395
2. Marsh JC, Ball SE, Cavenagh J, Darbyshire P, Dokal I, Gordon-Smith EC, Keidan J, Laurie A, Martin A, Mercieca J, Killick SB, Stewart R, Yin JA, British Committee for Standards in Haematology (2009) Guidelines for the diagnosis and management of aplastic anaemia. Br J Haematol 147 (1):43-70. doi:https://doi.org/10.1111/j.1365-2141.2009.07842.x
3. Aplastic Anemia and MDS International Foundation. Aplastic Anemia. (2017). http://www.aamds.org/diseases/aplastic-anemia. Accessed January 5, 2018
4. Heimpel H (2000) Epidemiology and aetiology of aplastic anaemia. In: Schrezenmeier HA, Bacigalupo A (eds) Aplastic anaemia: pathophysiology and treatment. Cambridge University Press, Cambridge, UK, pp 97–116
5. Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, Young NS (2006) The epidemiology of aplastic anemia in Thailand. Blood 107(4):1299–1307. https://doi.org/10.1182/blood-2005-01-0161
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献